- Reata Pharmaceuticals ( NASDAQ: RETA ) is scheduled to announce Q2 earnings results on Monday, August 8th, before market open.
- The consensus EPS Estimate is -$1.97 (-49.2% Y/Y) and the consensus Revenue Estimate is $1.46M (-34.2% Y/Y).
- Over the last 2 years, RETA has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.
For further details see:
Reata Pharmaceuticals Q2 2022 Earnings Preview